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In Brief
Orbitrap Exploris 480 MS with
FAIMS Pro provides fast, sensi-
tive and robust profiling of pro-
teomes when combined with
Evosep One. The combination of
Data Independent Acquisition
(DIA) and FAIMS with single
compensation voltages enables
analysis of up to 2000 peptides
per LC gradient minute and
more than 5000 protein groups
in twenty minutes. DIA-FAIMS
based label-free quantitation
achieves similar depth and
quantitative accuracy as the
well-established isobaric label-
ling approaches, but with less
LC-MS measurement time, mak-
ing it a good choice for large
cohort of samples.
Graphical Abstract
Throughput
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Sensitivity
Highlights
• Increased proteome coverage with Orbitrap Exploris 480 MS and FAIMS using single compensation
voltages and short LC gradients.
• Towards single-cell proteomics with high-sensitivity analysis of 5 ng HeLa with more than 1,000
proteins identified in 5 minutes using FAIMS and DIA.
• Deep proteome profiling across twelve rat organs tissues by label-free quantitation using DIA
compared to TMT-multiplexing and turboTMT acquisition using phi-SDM.
• Rapid and sensitive phosphoproteomics with automated enrichment using Ti-IMAC magnetic beads
and direct DIA analysis.
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A Compact Quadrupole-Orbitrap Mass
Spectrometer with FAIMS Interface Improves
Proteome Coverage in Short LC Gradients*□S
Dorte B. Bekker-Jensen‡**, Ana Martínez-Val‡, Sophia Steigerwald‡, Patrick Ru¨ther‡,
Kyle L. Fort§, Tabiwang N. Arrey§, Alexander Harder§, Alexander Makarov§,
and Jesper V. Olsen‡¶
State-of-the-art proteomics-grade mass spectrometers
can measure peptide precursors and their fragments with
ppm mass accuracy at sequencing speeds of tens of
peptides per second with attomolar sensitivity. Here we
describe a compact and robust quadrupole-orbitrap mass
spectrometer equipped with a front-end High Field Asym-
metric Waveform Ion Mobility Spectrometry (FAIMS) In-
terface. The performance of the Orbitrap Exploris 480
mass spectrometer is evaluated in data-dependent acqui-
sition (DDA) and data-independent acquisition (DIA)
modes in combination with FAIMS. We demonstrate that
different compensation voltages (CVs) for FAIMS are op-
timal for DDA and DIA, respectively. Combining DIA with
FAIMS using single CVs, the instrument surpasses 2500
peptides identified per minute. This enables quantification
of>5000 proteins with short online LC gradients delivered
by the Evosep One LC system allowing acquisition of 60
samples per day. The raw sensitivity of the instrument is
evaluated by analyzing 5 ng of a HeLa digest from which
>1000 proteins were reproducibly identified with 5 min LC
gradients using DIA-FAIMS. To demonstrate the versatil-
ity of the instrument, we recorded an organ-wide map of
proteome expression across 12 rat tissues quantified by
tandem mass tags and label-free quantification using DIA
with FAIMS to a depth of >10,000 proteins. Molecular &
Cellular Proteomics 19: 716–729, 2020. DOI: 10.1074/mcp.
TIR119.001906.
Deep proteome profiling of human cells can now be routinely
achieved by shotgun proteomics using the latest advances in
nanoflow liquid chromatography tandem mass spectrometry
(LC-MS/MS) (1,2). However, comprehensive analysis of a hu-
man proteome typically requires days of mass spectrometric
measurement time (3), making high-throughput analysis chal-
lenging and time-consuming. Therefore, new improved mass
spectrometric technology and acquisition strategies are needed
to overcome these limitations in current large-scale proteomics.
The Orbitrap analyzer has become one of the major players in
mass spectrometry-based proteomics (4). We have previously
described the performance enhancement achieved over the
different generations of the popular benchtop quadrupole-Or-
bitrap instruments, the Q Exactive™ series, for proteomics ap-
plications (5–7). The previous generation Q Exactive HF-X™
hybrid quadrupole-Orbitrap instrument incorporated a new
peak-picking algorithm, a brighter ion source, and optimized ion
transfers enabling productive HCD-MS/MS (8) acquisition
above 40 Hz. These improvements collectively resulted in in-
creased peptide and protein identification rates of up to fifty
percent at short LC-MS gradients with more than 1000 unique
peptides identified per minute (7). However, instrument per-
formance after extended periods of continuous sample analy-
ses could be comprised by contaminants entering the quadru-
pole and resulting in local charging and lower MS/MS
sensitivity. This meant that regular preventative maintenance
could be necessary to preserve high performance of the Q
Exactive HF-X instrument. Moreover, the semi-stochastic na-
ture of the data-dependent acquisition (DDA)1—the most pop-
ular tandem mass spectrometric acquisition strategy may cre-
ate issues with reproducibility of peptide measurements
between samples leading to the so-called missing value prob-
lem. To overcome the precursor selection problem inherent to
DDA, data-independent acquisition (DIA) offers systematic
measurement of all peptide ions regardless of their intensity by
co-fragmenting all co-eluting peptides in broader precursor iso-
lation windows. This provides wider dynamic range of the pro-
teomes analyzed, improved reproducibility for identification and
enabled better sensitivity and accuracy for quantification. The
highly multiplexed fragment ion spectra in DIA require more
elaborate processing algorithms for identification and quantifi-
cation. These typically rely on spectral libraries previously re-
corded by data-dependent acquisition of similar sample types.
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The front-end high-field asymmetric waveform ion mobility
spectrometry (FAIMS) (9–11) interface functions as an ion
selection device and an electrospray filter that prevents neu-
trals from entering the orifice of the mass spectrometer while
reducing chemical background noise. This “purification” of
the electrosprayed ions typically results in improved robust-
ness and sensitivity for proteomics experiments. The FAIMS
Pro interface continuously selects and focuses ions at atmo-
spheric pressure based on their differential mobilities in a high
field versus a low electric field established by applying an
asymmetric (e.g. bi-sinusoidal) voltage to at least one of the
inner and outer electrodes. To prevent an ion species from
being discharged, the FAIMS Pro interface applies a small DC
potential, called the compensation voltage (CV), to the inner
electrode to compensate for the ion drift resulting from the
applied asymmetric waveform. Selection of an ion species is
based on a combination of its gas-phase charge-state and
collisional cross-section. CVs can be tuned such that only
selected subsets of ions are transmitted through the elec-
trodes thereby favoring multiply-charged peptide species and
filtering out singly-charged chemical background ions. The
CV is typically negative for positive ions and positive for
negative ions. The advantage of FAIMS in the context of
large-scale proteomics on the Tribrid™ Orbitrap systems (i.e.
those incorporating a quadrupole mass filter and dual-pres-
sure linear quadrupole ion trap in addition to the Orbitrap
mass analyzer) has previously demonstrated to improve pro-
teome coverage for single-shot proteomics with long gradi-
ents by CV sweeping (11) and reduce ratio compression in
TMT experiment (12–14). However, potential advantages of
FAIMS for short gradients using single CVs have not been
explored. Likewise, FAIMS in combination with DIA has not
yet been investigated. Here we describe a thorough perform-
ance evaluation of the hybrid quadrupole-Orbitrap Exploris
480TM MS in combination with short LC gradients using the
Evosep One system. Standard DDA in combination with
FAIMS identifies more proteins but fewer peptides resulting in
a compromise between sequence coverage and proteome
depth. This is not the case for DIA, where FAIMS results in
identification of more proteins while maintaining the number
of peptide identifications.
EXPERIMENTAL PROCEDURES
Cells—Human epithelial cervix carcinoma HeLa cells were cultured
in DMEM (Gibco, Invitrogen), supplemented with 10% fetal bovine
serum, 100U/ml penicillin (Invitrogen), 100 g/ml streptomycin (Invit-
rogen), at 37 °C, in a humidified incubator with 5% CO2.
Lysis—Cells were harvested at80% confluence by washing twice
with PBS (Gibco, Life technologies) and subsequently adding boiling
lysis buffer (5% sodium dodecyl sulfate (SDS), 5 mM tris(2-carboxy-
ethyl)phosphine (TCEP), 10 mM chloroacetamide (CAA), 100 mM Tris,
pH 8.5) directly to the plate. The cell lysate was collected by scraping
the plate and boiled for an additional 10 min followed by micro tip
probe sonication (Vibra-Cell VCX130, Sonics, Newtown, CT) for 2 min
with pulses of 1 s on and 1 s off at 80% amplitude. Protein concen-
tration was estimated by BCA.
Rat Tissue Preparation—The study was carried out following ap-
proved national regulations in Denmark and with an animal experi-
mental license granted by the Animal Experiments Inspectorate, Min-
istry of Justice, Denmark. Three male Sprague-Dawley rats (Crl/S.D.,
male, 200 g, Charles River, Germany) were anesthetized with isoflu-
rane. The animals were perfused (1.5 min, 30 ml/min) with isotonic
saline containing protease inhibitors (0.120 mM EDTA, 14 M apro-
tinin, 0.3 nM valine-pyrrolidide and Roche Complete Protease Inhibitor
tablets (Roche), pH  7.4). Tissues were quickly removed and snap
frozen in isopentane on dry ice. Frozen organs were heat inactivated
(Denator T1 Heat Stabilizor, Denator) and a portion of each tissue was
transferred to an SDS solution (5% SDS, 25 mM Tris, pH 8.5) and
homogenized by ceramic beads using steps of 20 s at 5500 rpm
(Precellys 24, Bertin Technologies) until all tissue was clarified. The
tissues were heated for 10 min at 95°C followed by micro tip sonica-
tion on ice and clarified by centrifugation (20 min, 16,000  g, 4°C).
Samples were reduced and alkylated by adding 5 mM tris(2-carboxy-
ethyl)phosphine and 10 mM chloroacetamide for 20 min at room
temperature.
Automated PAC Digestion—Protein digestion was automated on a
KingFisher™ Flex robot (Thermo Fisher Scientific) in 96-well format.
The 96-well comb is stored in plate #1, the sample in plate #2 in a final
concentration of 70% acetonitrile and with magnetic Amine beads
(ReSyn Biosciences) in a protein/bead ratio of 1:2. Washing solutions
are in plates #3–5 (95% Acetonitrile (ACN)) and plates #6–7 (70%
Ethanol). Plate #8 contains 300 l digestion solution of 50 mM am-
monium bicarbonate (ABC), LysC (Wako) in an enzyme/protein ratio
of 1:500 (w/w) and trypsin (Sigma Aldrich) in an enzyme:protein ratio
of 1:250. The protein aggregation was carried out in two steps of 1
min mixing at medium mixing speed, followed by a 10 min pause
each. The sequential washes were performed in 2.5 min and slow
speed, without releasing the beads from the magnet. The digestion
was set to 12 h at 37 degrees with slow speed. The workflow is
illustrated in supplemental Fig. S5A. Protease activity was quenched
by acidification with trifluoroacetic acid (TFA) to a final concentration
of 1%, and the resulting peptide mixture was concentrated on Sep-
Pak (C18 Classic Cartridge, Waters, Milford, MA). Peptides were
eluted with 2 ml 40% ACN, followed by 2 ml 60% ACN. The combined
eluate was reduced by SpeedVac (Eppendorf, Germany) and the final
peptide concentration was estimated by measuring absorbance at
280 nm on a NanoDrop 2000C spectrophotometer (Thermo Fisher
Scientific). Peptides were preserved at 80 degrees for further anal-
ysis or loaded on EvoTips according to the manufacturer’s protocol.
High-pH Fractionation—Peptides were fractionated using a re-
versed-phase Acquity CSH C18 1.7 m 1 150 mm column (Waters,
Milford, MA) on an UltiMate 3000 high-pressure liquid chromatogra-
phy (HPLC) system (Thermo Fisher Scientific) operating at 30 l/
minute. Buffer A (5 mM ABC) and buffer B (100% ACN) were used.
Peptides were separated by a linear gradient from 5% B to 35% B in
55 min followed by a linear increase to 70% B in 8 min. 46 fractions
were collected without concatenation.
TMT Labeling—Rat peptides were TMT-labeled according to the
overview in supplemental Fig. S4A with 10 g of peptide and 4 l of
1 The abbreviations used are: DDA, data dependent acquisition;
ACN, acetonitrile; APD, advanced peak detection; DIA, data inde-
pendent acquisition; FAIMS, high-field asymmetric waveform ion mo-
bility spectrometry; FA, formic acid; HCD, higher-energy collisional
dissociation; HCTT, high capacity transfer tube; IT, maximum injec-
tion time; LC, liquid chromatography; m/z, mass-to-charge; MS, mass
spectrometry; MS/MS, tandem mass spectrometry; PSMs, peptide
spectrum matches; PTMs, post translational modifications; TFA, tri-
fluoroacetic acid; TMT, tandem mass tags.
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TMT reagent per channel. Labeling conditions were performed ac-
cording to manufacturer’s protocol. After labeling samples were
pooled, acidified and concentrated on SepPaks (C18 Vac C18 Car-
tridge, 1cc/50 mg 55–105 m Waters, Milford, MA). Peptides were
eluted with 300 l 40% ACN, followed by 300 l 60% ACN and by
300 l 80% ACN. The combined eluate was reduced by SpeedVac,
resuspended in 5 mM ABC and offline high pH reversed phase frac-
tionated as described above.
Automated Phosphopeptide Enrichment—Phosphopeptide enrich-
ment was carried out on a KingFisher™ Flex robot (Thermo Fisher
Scientific) in 96-well format as previously described (23,24) and also
outlined in supplemental Fig. S5B. Two hundred micrograms of peptide
were used for enrichments with 30 l of magnetic Ti-IMAC HP beads (a
prototype phosphopeptide enrichment product from ReSyn Biosci-
ences), which is an improved version of the commercially available
magnetic Ti-IMAC beads (ReSyn Biosciences). Briefly, the 96-well
comb is stored in plate #1, 30 l Ti-IMAC HP beads in 100% ACN in
plate #2 and loading buffer (1 M glycolic acid, 80% ACN, 5% TFA) in
plate #3. The sample volume is minimum doubled with loading buffer
while kept in a total of 300 l and added in plate #4. Plates 5–7 are filled
with 500 l washing solutions; loading buffer, 80% ACN, 5% TFA and
10% ACN, 0.2% TFA respectively. Plate #8 contains 200 l 1% am-
monia for elution. The beads were washed in loading buffer for 5 min at
medium mixing speed, followed by binding of the phosphopeptides for
20 min and medium speed. The sequential washes were performed in 2
min and fast speed. Phosphopeptides were eluted in 10 min at medium
mixing speed. The eluate is acidified with TFA and loaded directly on
EvoTips.
Design of a Quadrupole Orbitrap Instrument—The Orbitrap Exploris
480 instrument (Thermo Fisher Scientific, Bremen, Germany) includes
an atmospheric pressure ion source (API) interfaced to a radio-fre-
quency ion funnel via a high-capacity transfer tube (HCTT), a quadru-
pole mass filter, a C-trap, an ion routing multipole (IRM), and an
ultra-high field Orbitrap mass analyzer. Ions are formed at atmo-
spheric pressure (in this work in a micro-electrospray ion source),
pass through the HCTT to the ion funnel as described in Martins and
coworkers (15) and then via a mass-selective injection flatapole as
described in Scheltema et al. (16), into a bent flatapole. The S-shaped
bent flatapole is implemented as two parallel printed circuit boards
(PCB) with metal rods forming 4 mm gap between its rods, oriented in
such a way that the line of sight from the HCTT is open for clusters
and droplets to fly unimpeded out of the flatapole onto a dump. Ions
are driven through the bent flatapole by an axial electric field created
by a voltage divider on PCB stripes. After collisional cooling in the
bent flatapole, ions are transmitted via a lens into a hyperbolic seg-
mented-rod quadrupole. A known issue of quadrupole mass filter
contamination has been addressed by introducing symmetrical ion
loading. In this mode the DC polarity of quadrupole rods is regularly
switched so that contamination becomes more symmetrical. After the
quadrupole, ions are transferred to the C-trap via a short octapole and
a split lens, now integrated with an independent charge detector. Ions
fly through accelerating-only metal lenses of the C-trap into a nitrogen
filled IRM and get trapped or fragmented there. The IRM pressure is
measured directly by a Pirani gauge and varies in the range from 3 to
10 microbar. As in all other Orbitrap instruments of the Q Exactive
(7,16,17) or Orbitrap FusionTM series (18), fragmentation of ions in the
IRM is achieved by adjusting the offset of the RF rods and the axial
field to provide the required collision energy. Similarly, multiple pre-
cursor ions could be fragmented at their optimum collision energy
without compromising the storage of preceding injections. Unlike
previous instruments, the IRM is implemented using the same tech-
nology as the bent flatapole, i.e. using 4 shaped metal rods soldered
to two PCBs separated by precision spacers. Also, a single RF supply
drives the C-trap, transport multipole, and IRM at 3.1 MHz. During the
return transfer to the C-trap, the same principle of electrodynamic
squeezing is applied as in the Orbitrap analyzer. Specifically, IRM
offset and C-trap lens voltages are slowly ramped up during the
transfer so that ions face an increasing potential barrier as they
approach lenses and therefore cannot get deposited on lens edges.
Once ions are cooled inside the C-trap, voltages on all its electrodes
are raised to the optimum for injection into the Orbitrap analyzer.
Unlike all previous designs of C-trap, the pull-out pulse is applied only
to the slotted electrode of the C-trap, which ensures strong ion
focusing upon extraction so that losses on the edges of the slot are
also reduced. Although reducing losses and contamination on the exit
slit, such extraction requires additional focusing downstream of the
C-trap with the help of an additional lens. The symmetrically suspended
ultra-high field Orbitrap analyzer is open to pumping on both ends and
combines better mechanical and electrical balancing with improved
vacuum inside the trap, enabling higher resolution analyses with acqui-
sition of longer transients. Ions are detected with 4 kV applied to the
trap, which is somewhat lower than 5 kV in Q Exactive or Orbitrap
Fusion series. Nevertheless, this still allows acquisition of transients at
resolution settings ranging from 7500 to 480,000 at m/z 200 (16 and
1024 ms transients, respectively) in 7 steps differing by a factor of 2. The
entire ion path from the ion funnel to Orbitrap analyzer is evacuated by
a single, purpose-developed, 6-stage turbo pump PM902619A (Pfeiffer
Vacuum, Asslar, Germany). UHV is realized without the use of knife-
edge sealings by a “chamber-in-chamber” solution in which the pump
also serves as a carrier for an inner chamber that houses the C-trap and
Orbitrap analyzer. Pressure stages were matched to pumping ports by
reducing the length of the hyperbolic-rod quadrupole mass filter, its
pre-filters, and transport multipoles, without performance impairment.
Ion funnel is evacuated by 120 m3/h single-stage rotary vane pump
(Sogevac® SV120 BI FC, Oerlikon Leybold Vacuum) and turbopump is
backed by a dedicated Sogevac SV15 pump.
Processing of Transients—Transients detected in the Orbitrap
mass analyzer are processed using an enhanced version of Fourier
Transformation (eFT™) as described in Lange et al. (19). For TMT
experiments, narrow m/z regions near TMT-10 reporter peaks (20,21)
were processed by Phase-constrained signal deconvolution method
(Phi-Transform) as described in Kelstrup et al. (22). This allowed use
of special transient durations of 32 ms (resolution setting 15,000 at
m/z 200) specifically for resolving isobaric TMT reporter ions in TMT
11-plex experiments.
FAIMS Pro—The new mass spectrometer shares several features
with the latest Tribrid instruments such as the Orbitrap Fusion
Lumos™ mass spectrometer and Orbitrap Eclipse™ Tribrid mass
spectrometer. It has the same ion source, atmosphere-to-vacuum
interface and user-facing software as the Orbitrap Fusion Lumos™
mass spectrometer. The shared design of the Orbitrap Exploris 480
mass spectrometer also enables it to be interfaced to the same
front-end options that are available with the Tribrid instruments, such
as the FAIMS Pro™ device and internal calibrant (EASY-IC™) source.
Details of FAIMS Pro design and its characterization are presented in
Pfammatter et al. (13). The unique feature of FAIMS Pro is the use of
cylindrical electrodes that help to focus ions through the electrode
assembly as they get carried by nitrogen carrier gas from front to
back. With inner electrode blocking “line of sight” for clusters and
dust particles, the additional benefit of interface protection from en-
vironmental effects is achieved. As this work uses higher flow rates
than in previous nanospray experiments, method of FAIMS Pro op-
eration includes an additional step of increased FAIMS carrier gas
setting at the beginning of the LC gradient.
LC-MS/MS—All samples were analyzed on the Evosep One sys-
tem using an in-house packed 15 cm, 150 m i.d. capillary column
with 1.9 m Reprosil-Pur C18 beads (Dr. Maisch, Ammerbuch, Ger-
many) using the pre-programmed gradients (60, 100, and 200 sam-
The Orbitrap Exploris 480 MS with FAIMS for Proteomics
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ples per day with flow rates of 1, 1.2 and 1.5 l/min respectively). The
column temperature was maintained at 60 °C using an integrated
column oven (PRSO-V1, Sonation, Biberach, Germany) and inter-
faced online with the Orbitrap Exploris 480 MS. Spray voltage were
set to 2 kV, funnel RF level at 40, and heated capillary temperature at
275 °C. For DDA experiments full MS resolutions were set to 60,000
at m/z 200 and full MS AGC target was 300% with an IT of 25 ms.
Mass range was set to 350–1400. AGC target value for fragment
spectra was set at 200% with a resolution of 15,000 and injection
times of 22 ms and Top12. Intensity threshold was kept at 2E5.
Isolation width was set at 1.3 m/z. Normalized collision energy was
set at 30%. For DIA experiments full MS resolutions were set to
120,000 at m/z 200 and full MS AGC target was 300% with an IT of
45 ms. Mass range was set to 350–1400. AGC target value for
fragment spectra was set at 1000%. 49 windows of 13.7 Da were
used with an overlap of 1 Da. Resolution was set to 15,000 and IT to
22 ms. Normalized collision energy was set at 27%. All data were
acquired in profile mode using positive polarity and peptide match
was set to off, and isotope exclusion was on. Default settings were
used for FAIMS with voltages applied as described in the manuscript,
except gas flow, which was applied with 3 L/min in the first minute of
the method and spray voltage which was set to 2.3 kV. For TMT
experiments the turbo-TMT was enabled, MS/MS data was recorded
in centroid mode. Isolation window was set to 0.7 Da and first mass
was set to 100 m/z.
Rat Tissue Specific Library Generation—A pool from each tissue
was generated using 40 g of peptide from a given tissue from each
independent rat. Each of the tissue pools were fractionated using
high-pH reversed phase fractionated as described above into 46 frac-
tions. For each tissue, the fractionated proteome was analyzed twice on
the Evosep One with the column details described above and using the
pre-programmed gradient (200 samples per day). Around 250 ng from
each fraction was analyzed on a Q-Exactive HF-X using a MS/MS
resolution of 15,000, injection time of 22 ms and a Top12 method.
Another 250 ng was then analyzed on an Orbitrap Fusion Lumos with
FAIMS using a MS/MS resolution of 30,000, injection time of 54 ms and
a Top6 method and a CV of 45 V for FAIMS.
Raw Data Processing—All DDA raw files were processed with
MaxQuant (25) v1.6.7.0 using the integrated Andromeda Search en-
gine (26). All HeLa data is searched against a target/decoy version of
the human Uniprot Reference Proteome without isoforms (21,074
entries), whereas all rat files are searched against the rat Uniprot
Reference Proteomes with and without isoforms (21,662 entries 
9,900 entries for isoforms) and the mouse Uniprot Reference Pro-
teome without isoforms (22,286 entries),all with January 2019 release.
First search peptide tolerance was set to 20 ppm, main search
peptide tolerance was set to 4.5 ppm. Fragment mass tolerance was
set to 20 ppm. Trypsin was specified as enzyme, cleaving after all
lysine and arginine residues and allowing up to two missed cleavages.
Carbamidomethylation of cysteine was specified as fixed modifica-
tion and protein N-terminal acetylation, oxidation of methionine,
deamidation of asparagine and glutamine and pyro-glutamate forma-
tion from glutamine were considered variable modifications with a
total of 2 variable modifications per peptide. “Maximum peptide
mass” were set to 7500 Da, the “modified peptide minimum score”
and “unmodified peptide minimum score” were set to 25 and every-
thing else was set to the default values, including the false discovery
rate limit of 1% on both the peptide and protein levels. The TMT
proteomes were searched independently with further specification of
TMT 11-plex as label with a reporter ion mass accuracy of 0.002 Da.
For the rat proteomes, 12 different searches were performed inde-
pendently with the “match between runs” feature enabled between
fractions. All DIA raw files were processed with Spectronaut version
13 (Biognosys, Zurich, Switzerland). Project specific spectral libraries
were imported from the separate MaxQuant analyzes of the com-
bined analysis of the 2  46 pre-fractionated fractions of each tissue,
and DIA files were analyzed using default settings disabling the PTM
localization filter. Mass tolerance/accuracy for precursor and frag-
ment identification was set to default settings. Up to 6 fragments were
employed for library generation. FDR at peptide and protein level was
set to 1% using a mutated decoy model (27). For matching of DIA
data to spectral library, the applied mass and retention time toler-
ances (for both MS1 and MS2) are dynamic based on the m/z of the
targeted ion and the retention time of the scan. The calibration is done
for each run individually.
Phospho-enriched samples from rat tissues were processed in
Spectronaut using a library-free approach (directDIA) including phos-
phorylation on STY as a variable modification, Rat database with
isoforms and mouse database without isoforms were used for iden-
tification PTM localization cut-off was set to 0.75. Spectronaut v13
uses the localization algorithm as described in Bekker-Jensen et al.
(28).
Data Analysis—DIA results from each independent tissue were
merged by gene name. For quantification in DIA, we used standard
settings in Spectronaut (v13) for quantification at MS2 level. Proteins,
which were not quantified in all three replicates for at least one tissue
were discarded for further analysis. Missing values were imputed in
Perseus using values from a normal distribution (width  0.3, down-
shift  1.8). For quantification in TMT analysis, Reporter intensities
from proteinGroups.txt table were used. TurboTMT data was filtered
to remove proteins not quantified in all channels in three independent
experiments. Intensities across channels were log2 transformed and
normalized using quantile normalization. Batch effect between inde-
pendent TMT experiments was removed using “ComBat” function
implemented in the sva package (29) in R. For clustering, TMT and
DIA data were separately transformed by z-score. For comparison
with TMT, the average of duodenum, jejunum and ileum values for
each independent rat was used. Finally, proteins were clustered using
Euclidean distance in Perseus. Principal Component Analysis (PCA)
was performed using proteins quantified in all experiments (either DIA
or TMT), using the “prcomp” function in R. Phospho-DIA data was
searched with directDIA in Spectronaut and the report output col-
lapsed to either “modification-specific-peptide” or “phospho-site”
tables using the Perseus plugin previously described(28). Phospho-
site intensities were log2 transformed and missing values were im-
puted in Perseus using values from a normal distribution (width 0.3,
downshift  1.8). Afterward, intensities were normalized using loess
function implemented in the limma package in R, and ANOVA test
was performed using an FDR  1%. Phosphosite intensities were
z-score transformed and clustered using Euclidean distance.
Experimental Design and Statistical Rationale—Number of repli-
cates were denoted for all results where statistical analysis was
performed and marked in the figures. Figure legends provided further
clarification of statistical tests and criteria for determining significance
in each case. For HeLa single-shot analysis, the same digest was
frozen in aliquots and loaded on Evotips prior to analysis. Character-
ization of FAIMS CV settings were performed in duplicates for both
DDA and DIA, whereas technical triplicates were performed for the
remaining measurements at 60 samples per day and quadruplicate
measurements for the 200 samples per day runs. Rat tissues were
prepared from three independent rats and aliquots were frozen after
PAC digestion. Phosphopeptide enrichment were performed sepa-
rately from all samples.
RESULTS AND DISCUSSION
A Compact Quadrupole-Orbitrap Instrument for Proteom-
ics—The Orbitrap Exploris 480 mass spectrometer combines
a compact hybrid quadrupole-Orbitrap design with increased
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performance in high-throughput analysis. Compared with the
Q Exactive HF™ (16) and HF-X (7) mass spectrometers that
use the same combination of analyzers, the entire layout of
the instrument was reconfigured to enable a more compact
and robust platform, which is easier to service. Furthermore,
the bent flatapole, quadrupole, independent charge detector
and ion routing multipole were all redesigned to address the
enhanced requirements on the instrument. (Fig. 1A). However,
the backbone of the new design is a new pumping concept,
combined with a new layout of ion optics, C-trap electrodes,
and Orbitrap electrodes. The requirement of ultra-high vac-
uum (UHV) in the 10E-10 or even 10E-11 mbar range for
Orbitrap analysis of ions formed at atmospheric pressure has
previously necessitated a bulky, multi pump vacuum system,
which represented the major constraint on the overall design
and size of the instrument. The main technical innovation
realized in this new instrument concept is a single, purpose-
developed, six-stage turbo pump that evacuates the entire
path from the ion funnel to the Orbitrap analyzer. This enables
a drastic reduction of instrument footprint and volume and
enables easier access to all ion-optical components. Finally,
several added front-end devices were enabled, i.e. FAIMS Pro
interface and internal calibrant (EASY-IC) source, to extend
the functionality of the instrument. Although atmosphere-to-
vacuum interface and most ion-optical elements are quite
similar in function and performance between the Q Exactive
HF-X and the Orbitrap Exploris 480 MS instruments, a num-
ber of improvements were introduced to operation of the
new mass spectrometer as described under Experimental
Procedures.
Data-dependent Acquisition with FAIMS—To evaluate the
performance of the instrument for proteomics we analyzed
single-shot HeLa proteomes using short LC gradients both
with and without FAIMS. HeLa cervix carcinoma cells were
harvested in 5% SDS buffer and tryptic digests were prepared
using an automated workflow by protein aggregation capture
(PAC) (30) and proteolytic digestion with endoproteinase
Lys-C and trypsin on magnetic beads using a KingFisher™
Flex robot (24). To minimize overhead time between LC-
MS/MS runs and maintain robustness and reproducibility of
LC separations over hundreds of injections, we made use of
the Evosep One (31) system with short gradients in the range
from 5 to 21 min enabling analysis of 60–200 samples per
day. Although it utilizes a fundamentally different design, the
Orbitrap Exploris 480 MS can achieve the same MS/MS scan-
ning speed as the Q Exactive HF-X instrument when using the
same transient and maximum injection times for optimal par-
allel mode of acquisition (7). All DDA experiments were there-
fore performed with a fast scanning top12 method encom-
passing a MS1 survey scan recorded at 60,000 resolution
followed by twelve HCD scans with maximum allowed injec-
tion time of 22 ms and 15,000 resolution equivalent of 28 Hz
MS/MS scan speed (Fig. 1B). To identify the optimal FAIMS
settings for maximum proteome coverage we performed a
systematic stepwise CV sweep from 80 V to 30 V with 5 V
intervals and benchmarked the number of peptides and pro-
teins identified at each CV setting with a standard DDA run
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without FAIMS. With 500 nanograms of HeLa peptides in-
jected on column and analyzed with the 21 min (60 samples
per day) gradient we observed a similar peptide distribution
across the CV range as shown previously (11) with maximum
peptide identification for CV of 50 V (Fig. 1C and supple-
mental Table S1). All DDA files were analyzed with MaxQuant
(25) applying a one percent false discovery rate (FDR) at both
peptide and protein level. The reproducibility and separation
power of the FAIMS device judged by the replica runs sug-
gests that a difference of more than 10 V between CVs is
required to minimize overlaps (supplemental Fig. S1A). At a
CV of 40 V and lower, singly-charged precursors were sig-
nificantly reduced, whereas multi-charged precursors are
spread across the CV range (supplemental Fig. S1B). None of
the FAIMS files resulted in the same number of identifications
as the run without FAIMS at 12,700 peptides. Conversely, all
FAIMS runs except the one with a CV of 30 V achieved
significantly higher number of protein identifications with a CV
of 75 V providing the best coverage with 3473 proteins
(representing 38% more than the 2515 proteins identified
without FAIMS). However, the increased proteome depth with
FAIMS comes at a cost of lower sequence coverage at single
CVs (Fig. 1D). Surprisingly, a CV of 75 V provides the best
protein coverage, but the smallest number of peptides result-
ing in only about three peptides per protein on average (Fig.
1D supplemental Table S1). At a CV of 75 V, we are oper-
ating at the edge of the peptide intensity distribution whereby
a very small fraction of peptides is transmitted through the
FAIMS device. The success of this CV setting is therefore
highly dependent on the general performance of the instru-
ment, as any loss in sensitivity will immediately result in a
dramatic decrease in protein identification. It only works well
when the total ion flux in MS/MS mode is high as measured by
total ion current chromatogram (TIC) distributions plot (sup-
plemental Fig. S1C). To assess the dynamic range of the
proteins covered we overlapped the identifications with the
deepest HeLa proteome to date with copy number estimates
for 12,600 protein-coding genes (3). In the DDA-FAIMS ex-
periments, we not only cover more proteins compared with
the DDA without FAIMS, but we are also able to dig deeper
into the HeLa protein abundance distribution covering signif-
icantly more of the dynamic range (Fig. 1E). The observed
increase in the number of proteins identified with FAIMS op-
erated with a CV of75 V compared with runs without FAIMS
is true for all gradients tested with even higher gains at shorter
gradients, possibly because of concentration of the MS/MS
signal intensity (Fig. 1F). We observed a 41% and 48% gain in
number of proteins identified using gradients for 200 samples
and 100 samples per day, respectively (Fig. 1F). Previously, it
has been shown that in longer gradients switching CVs inter-
nally during the LC-MS/MS analysis improves peptide cover-
age11. However, with a current overhead time of 25 ms be-
tween individual single CVs, it is more suitable for gradients
longer than the ones used in the current study.
Data-independent Acquisition with FAIMS—Next, we
wanted to test if the benefits of applying FAIMS with a single
CV could be extended to DIA. We again started by performing
a CV sweep from 80 V to 35 V in steps of 5 V and
compared the number of quantified peptides at each CV with
an equivalent LC-MS/MS run without FAIMS. All DIA files
were analyzed using the 60 samples per day gradient and
processed with Spectronaut(23) software using a project-
specific spectral library recorded at the same chromatogra-
phy settings consisting of 105,000 tryptic HeLa peptides
and nearly 10,000 proteins for the analysis. We previously
demonstrated that DIA provides higher proteome coverage
than DDA with short gradients on a Q Exactive HF-X instru-
ment (7). This is also the case with the Orbitrap Exploris 480
MS whereby we identified up to 4587 HeLa proteins in a single
run using DIA, which corresponds to 35% more proteins than
by DDA. Importantly, in contrast to the DDA-FAIMS analysis,
we found that FAIMS-DIA worked best at a CV of 45 V with
more identifications of peptides and 5138 proteins compared
with a DIA run without FAIMS (Fig. 2A and supplemental Table
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S2). Furthermore, DIA-FAIMS reaches impressive identifica-
tion rates of up to 2500 peptides per minute of gradient time
(Fig. 2B). This translates to a consistent gain in protein iden-
tifications across the gradient for DIA-FAIMS compared with
classic DIA (Fig. 2C). These results highlight how the use of
FAIMS in DIA mode not only increases proteome coverage,
but also maintains the peptide identification rate in DIA mode
without FAIMS. Even though FAIMS mobility separation re-
sults in a reduction in measured fragment ions, the increase in
proteins identified is the result of more ions being sampled in
MS/MS mode in DIA-FAIMS compared with DDA (supplemen-
tal Fig. S2A–S2B). In proteomics, it is not only central to
identify as many peptides and proteins as possible but high
quantitative precision is equally important. To test the impact
of FAIMS on the quantitative accuracy, we analyzed the re-
producibility of protein intensities between replicates. For
DIA-FAIMS 71% of the 5,138 identified proteins were repro-
ducibly quantified with a coefficient of variation below 20 and
54% with a coefficient of variation below 10% (Fig. 2D). In
contrast, DIA analyzes without FAIMS decreased the number
of consistently quantified proteins with a coefficient of varia-
tion below 20% to 2,829 representing only 60% of the total
4,584 proteins quantified (Fig. 2D). Importantly, this highlights
that no compromise on quantitative accuracy is observed for
the additional proteins identified with DIA-FAIMS. Compared
with DDA-FAIMS, we observe that around 50% additional
proteins identified in DIA-FAIMS match the same proteome
abundance distribution range (Fig. 2E).
Sensitive Analysis with FAIMS and Very Short Gradients—
Given the significant increase in protein identifications with
500 ng HeLa digest analyzed with FAIMS using the 60 sam-
ples per day gradient, we wondered whether this gain could
also be achieved at decreased sample load. We analyzed 5 ng
of tryptic peptides loaded on column equivalent to 30–50
HeLa cells. For optimal sensitivity, the gradient was shortened
to 5 min (200 samples per day) and samples were analyzed
using both DDA and DIA with and without FAIMS. For such
low amounts, it is required to enhance the MS/MS sensitivity
by increasing the resolving power and injection times to
30,000 resolution and 54 ms, respectively. Moreover, we ob-
served that a slightly shifted CV to 50 V is optimal (supple-
mental Fig. S3A). To maintain good quantitative accuracy it is
required to reduce the cycle time from 2 s to 1 s (supplemental
Fig. S3B). The very low amount is a challenge for standard
DDA, where we only identify 26 proteins (Fig. 3A). With DDA-
FAIMS, the identifications increased by a factor of 10 to 281
proteins (Fig. 3A). On the other hand, classic DIA further
increased proteins identified to 547, whereas DIA-FAIMS is
superior with more than 1,000 proteins identified (Fig. 3A
supplemental Table S3). Additionally, FAIMS enhanced the
reproducibility of DIA quantification, based on the number of
proteins quantified with coefficient of variation below 20%
(Fig. 3B). The observed 10-fold increase in number of proteins
for the DDA-FAIMS compared with DDA without FAIMS sug-
gests that DDA-FAIMS is ideally suited for DDA analysis of
very low input material. The main reason for this is that FAIMS
is capable of effectively removing the singly-charged back-
ground ions from ambient air and the electrospray buffer,
which otherwise take up a lot of C-trap capacity when minute
amounts of peptide mixtures are analyzed (Fig. 3E). This issue
is best illustrated by the scaled total ion current chromato-
grams (TICs), where the background level in the DDA exper-
iment is very high (Fig. 3C), whereas with DDA-FAIMS the
background is very low and hence the peptide signals are
significantly higher (Fig. 3D). This enhancement in the spectral
quality by FAIMS is also striking when quantifying the number
of ions measured in the full-scan MS1 spectrum during the
gradient, where FAIMS has a much lower starting background
level but 10-fold higher levels during peptide elution from 1.5
to 4 min (Fig. 3F).
Rat Tissue Specific Protein Atlas—The ability to quantify
proteins and their post-translational modifications between
cell states or cell types at a large scale is important for
understanding protein regulation and dynamics in health and
disease. The Orbitrap Exploris 480 mass spectrometer pro-
vides high sequencing speed and sensitivity and is therefore
well suited for deep proteome profiling across many condi-
tions. To identify the optimal quantitative proteomics work-
flow for large-scale proteome expression studies, we com-
pared tandem mass tags (TMT11-plex) with DIA-based
label-free quantification of 12 tissues covering the major
mammalian organs from three individual male rats (Fig. 4A).
To preserve the in vivo state of the organ proteomes and
phosphoproteomes, the excised tissues were heat-inacti-
vated33 and homogenized in 5% SDS buffer. Extracted pro-
teins were PAC precipitated on magnetic beads and digested
with Lys-C and trypsin. All LC-MS/MS experiments were an-
alyzed using the 21 min gradient (60 samples per day) on the
Evosep One. For the DIA-based label-free quantification we
analyzed each sample with the application of FAIMS to eval-
uate if it also provides benefits for complex organ proteome
analyzes. Because spectral libraries are required for DIA, we
performed deep proteome profiling by offline high-pH (HpH)
reversed phase fractionation of the organ digests and ana-
lyzed each fraction by DDA analysis with and without FAIMS.
Analyzing 46 HpH fractions from each of the 12 tissues
FAIMS at CV of 45 V resulted in 1104 LC-MS/MS runs.
Although each tissue required 32 h of LC-MS measurement
time, all tissues collectively needed 18.4 days of total mass
spectrometric measurement time. The peptide coverage in
each tissue varied from 50,000 unique peptides identified in
skeletal muscle to 100,000 identified in testis (Fig. 4B). The
number of identified peptides generally correlates with the
number of proteins identified in each organ with testis repre-
senting more than ten thousand proteins (Fig. 4C). Combining
the DDA analyzes with and without FAIMS slightly improves
the depth of the library on both peptide and protein level. The
observed discrepancy in identifications likely reflects the dif-
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ferences in protein expression levels across different organ
proteomes, where highly abundant contractile proteins such
as myosin dramatically increases the dynamic range of the
expressed muscle proteome (34) This high-quality dataset
representing 213,000 unique peptides covering 12,909 pro-
tein-coding genes should represent a resource for the pro-
teomics community, which can be bioinformatically mined or
used as a general rodent spectral library for future DIA
experiments.
Quantitative Rat Organ Protein Atlas by TMT and DIA-
LFQ—We have previously demonstrated that it is possible to
baseline resolve the isobaric TMT11-plex report ions in HCD
scans recorded with 15,000 resolution and processed with
phase-constrained spectrum deconvolution (phi-SDM), which
resulted in 	50% more identifications with 	99% quantified
proteins compared with standard settings (22). This phi-SDM
method is implemented as a standard scan option termed
Turbo-TMT in the methods editor for the Orbitrap Exploris 480
MS. Consequently, all TMT experiments were recorded with
Turbo-TMT to maximize proteome coverage. To fit the 12
organs into a single TMT11-plex experiment, we pooled the
duodenum, jejunum and ileum samples into one combined
small intestine sample. Likewise, to increase reproducibility in
peptide sequencing and enhance quantitative precision by
facilitating normalization across the replicate batches, we in-
cluded a common reference sample created by mixing ali-
quots of all tissues, in each of the three TMT11-plex batches
covering the 10 organs from the three animals (supplemental
Fig. S4A). To maximize proteome coverage in the TMT exper-
iments, we performed offline HpH chromatography and col-
lected 46 fractions, which we analyzed by online DDA-based
LC-MS/MS using the turbo-TMT method. In contrast, for la-
bel-free quantitation we performed single-shot DIA-FAIMS
experiments using the individual organ-specific spectral li-
braries for identification matching in Spectronaut. Conse-
quently, the DIA experiments of the 12 organs analyzed in
biological triplicates were performed in just 14 h of LC-
MS/MS analysis time (except the time needed for generating
the spectral library), whereas the three TMT11-plex batches
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FIG. 3. A, Bar chart showing the number of proteins identified in
5 min gradients (200 samples per day) using 5 ng load. Light green
bars correspond to DDA acquisition settings, dark green bars corre-
spond to DDA with optimal CV with FAIMS, light blue bars correspond
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Plotted values are the average between at least three replicates. B,
Bar chart showing the number of proteins quantified with a coefficient
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without FAIMS (light blue). C, Chromatogram of a DDA run from 5 ng
using a 5 min gradient showing the relative abundance of the total ion
current signal. D, Chromatogram of a DDA run with FAIMS (CV 75)
from 5 ng using a 5 min gradient showing the relative abundance of
the total ion current signal. E, Histogram showing the abundance
distribution of precursors with charge 1 during a 5 min gradient
using a sample loading of 5 ng in a DDA run (light green) or a DDA with
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required 2.3 days of total mass spectrometric analysis time
(Fig. 4A). Both quantification strategies resulted in compara-
ble proteome coverage with more than ten thousand proteins
quantified in total. More than eight thousand protein-coding
genes were reproducibly quantified in all three TMT experi-
ments, where each TMT set corresponds to one single rat
(supplemental Table S4). In contrast, DIA-FAIMS highlights
the tissue specificity of the proteomes with variable number of
protein groups identified per tissue, from more than 5000
proteins in testis to 2000 proteins on average in muscle (sup-
plemental Fig. S4B). Importantly, merging the protein coding
genes quantified in each tissue in all three rats resulted in
more than 8,000 proteins (Fig. 5A and supplemental Table
S5), achieving a similar coverage as in TMT. This yields iden-
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tification rates of more than 600 proteins per minute for DIA
(Fig. 5B). To remove the batch bias between TMT experi-
ments, we used ComBat normalization (29) and compared the
normalized protein abundance reproducibility between the
biological replica experiments for both TMT and DIA. We
generally observed high reproducibility analyzing correlations
of the log2-transformed protein intensities with R-squared of
r2 0.93 for DIA (Fig. 5C) and r2 0.98 for TMT (Fig. 5D). The
higher correlation for TMT experiments likely reflects the
greater number of peptides identified per protein on average
(35). To compare the reproducibility of the three biological
replicates of all the rat organ proteomes analyzed by TMT and
DIA, respectively, we performed a principal component anal-
ysis (PCA) of the normalized protein intensity data for all
tissues. Both TMT and DIA data show excellent reproducibility
with replica always closer in PCA space than distances to
other tissues (Fig. 5E and Fig. 5F). The first component in the
DIA based quantification explains more of the variance than
for the TMT data - mainly separating the myocyte-rich tissues,
cardiac and skeletal muscle, from the other tissues, most
likely because of their higher dynamic range of protein abun-
dances. Unsupervised hierarchical clustering of relative pro-
tein abundances across tissues reveal very similar protein
expression patterns between DIA-FAIMS and TMT experi-
ments, suggesting that both quantification strategies provides
very similar biological insights (Fig. 5G). An advantage of
DIA-FAIMS in the employed experimental design is that it
allows us to evaluate the tissue-specificity of the rat pro-
teome. Therefore, we analyzed the distribution of proteins
across all tissues to differentiate tissue-specific versus glob-
ally expressed proteins. A larger proportion of the identified
proteins are tissue specific than commonly expressed with
more than two thousand of the identified proteins exclusively
found in one tissue and only about one thousand proteins
found in all tissues (Fig. 5H). By far most tissue-specific pro-
teins were found in testis (Fig. 5I), which is in line with obser-
vations made in other datasets of global tissue expression
profiling (36). To investigate the biological roles of the tissue-
specific versus the globally expressed proteins, we per-
formed a gene ontology (GO) enrichment analysis across
the protein-specific tissue distributions, and found that
globally expressed proteins are enriched for mitochondrial
proteins involved in oxidative phosphorylation, whereas
transcription factors (37) are generally tissue-specific pro-
teins (Fig. 5J). These findings are consistent with the
fact that cellular housekeeping functions such as ATP pro-
duction by oxidative phosphorylation is generic to all cell
types, whereas tissue specificity is facilitated by temporal
and spatial gene expression patterns, which are driven by
transcription factors (38).
Rapid, Sensitive and Deep Phosphoproteomics—The abun-
dance of a protein is not always a direct measure of its cellular
activity, which is often modulated by dynamic post-transla-
tional modifications (PTMs) (39). Site-specific protein phos-
phorylation is one of the most important PTMs regulating
essentially all cellular protein signaling networks by controlling
protein activity, subcellular localization, turnover and espe-
cially protein-protein interactions (40). We have previously
demonstrated that it is possible to reproducibly identify close
to five thousand unique phosphopeptides from 200 g TiO2-
enriched HeLa in-solution digest in just 15 min of LC-MS/MS
analysis on an Easy nLC1200 coupled to a Q Exactive HF-X
instrument (7). This is equivalent to an analysis throughput of
45 samples per day. We have now streamlined and auto-
mated the entire phosphoproteomics workflow on the King-
Fisher Flex robot incorporating on-bead PAC digestion and
magnetic Ti-IMAC phosphopeptide-enrichment, which enable
parallel preparation of up to 96 phosphopeptide samples (23)
(supplemental Fig. S5). Analyzing the phosphopeptides pre-
pared from 200 g HeLa using data-dependent acquisition
with the 28 Hz HCD method on the Orbitrap Exploris 480 MS
with the Evosep One using the 60 samples per day method
resulted in identification of more than eight thousand unique
phosphopeptides of which more than five thousand could be
localized confidently (41) to a single amino acid (Fig. 6A).
Consequently, the optimization of all steps in the entire
workflow increases the coverage of the same HeLa phos-
phoproteome by more than fifty percent in shorter analysis
time. To test if this automated phosphoproteomics workflow
is also suitable for tissue samples, we analyzed the phos-
phoproteomes of the 12 organ tissues from the three indi-
vidual rats. We recently demonstrated that a spectral
library-free DIA search, directDIA, of phosphopeptide en-
riched samples is superior to DDA (28). We therefore ap-
plied this acquisition strategy to analyze the 36 samples,
which only required 14 h of MS instrument time, and re-
sulted in the identification of more than 22,000 unique pep-
tide variants and more than 13,000 localized phosphosites
(Fig. 6B and supplemental Table S6). Unsupervised hierar-
chical clustering of z-scored and log-transformed phospho-
rylation site intensities revealed high correlation between
replica of the same tissue and tissue-specific phosphoryla-
tion patterns (Fig. 6C). To identify protein kinases that ex-
hibit tissue-enhanced activity, we mapped all known ki-
nase-substrates from PhosphoSitePlus (42) onto our
dataset and calculated the fraction of known substrates
identified in our dataset for each kinase in 1 to 12 tissues.
This analysis revealed that CAMK2A is the most tissue-
specific kinase with one-third of the identified substrates
unique to a single tissue (Fig. 6D). Cluster analysis high-
lighted heart tissue as the organ with the highest CAMK2A
activity, where it phosphorylates proteins involved in car-
diac muscle contraction (43) (Fig. 6E). Conversely, the
known substrates of cAMP-dependent protein kinase
(PKACA) were more uniformly distributed across the tissues
(Fig. 6F–6G). The fast and sensitive organ phosphopro-
teomics profiling presented here demonstrated that there
are major differences in the phosphorylation patterns across
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tissues, and accordingly it can provide molecular insights
into which and how signaling pathways are regulated in a
tissue-specific manner.
CONCLUSION
The Orbitrap Exploris 480 MS is a compact hybrid quadru-
pole-Orbitrap mass spectrometer that provides high-quality
HCD tandem mass spectra at acquisition rates of up to 40 Hz,
which in combination with the Evosep One system, enables
routine identification of more than 1,000 unique peptides per
LC gradient minute. The application of FAIMS with a single CV
increased proteome coverage in short gradients by close to
50% in data-dependent acquisition-based shotgun proteom-
ics experiments of human cells at the expense of lower pep-
tide coverage. Importantly, FAIMS enables analysis of minute
sample amounts by effectively removing interfering singly-
charged background ions. We demonstrate that it is possible
to quantify more than 1,000 proteins from less than 50 HeLa
cells with DIA-FAIMS, highlighting its potential for applica-
tions such as laser microdissected clinical samples and sin-
gle-cell proteome analysis. The fast sequencing speed, high-
sensitivity and robustness of the Orbitrap Exploris 480 MS
makes it ideally suited for data-independent acquisition. The
combination of FAIMS and data-independent acquisition pro-
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vides more peptides identified and up to 5,100 mammalian
proteins quantified in single-shot analysis using short LC gra-
dients, allowing up to 60 samples to be measured in 24 h. This
acquisition strategy enables high-throughput and large-scale
profiling of hundreds of samples, as demonstrated by the
quantitative organ tissue atlas we provide here, which in-
cludes a high-quality spectral library consisting of more than
two hundred thousand unique peptides covering 12,900 pro-
tein-coding genes. This dataset comprises, to our knowledge,
the deepest rat proteome to date. This spectral library was
recorded by analyzing more than 1,000 LC-MS/MS runs of
offline high pH reversed-phase peptide fractions back-to-
back, which also demonstrates the robustness of the system
throughout large-scale applications. In addition to label-free
quantification the Orbitrap Exploris 480 MS is also optimized
for tandem mass tag-based quantification enabled by the fast
scanning turboTMT method. Additionally, we have presented
a comprehensive benchmark of DIA-FAIMS against the well-
established TMT-based quantification, showing that DIA-
FAIMS provides equivalent proteome coverage as isobaric
labeling. Interestingly, the observed biological reproducibility
in TMT-based quantification was higher than for DIA-FAIMS,
which likely reflects that all tissues from the same animal were
combined in one TMT set. The limitation of analyzing 11
samples within a single TMT experiment is now ameliorated
with the newly available TMT 16-plex reagents. Finally, the
instrument is also a good match for quantitative analysis of
post-translational modifications. Sensitive and large-scale anal-
ysis of cell line and organ phospho-proteomes is feasible in less
than 1 day of analysis. Consequently, we envision that it will be
find widespread use in many proteomics laboratories.
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